首页 | 本学科首页   官方微博 | 高级检索  
     

益气复脉颗粒联合常规西药治疗慢性心力衰竭临床研究
引用本文:王玲. 益气复脉颗粒联合常规西药治疗慢性心力衰竭临床研究[J]. 新中医, 2021, 53(5): 55-58
作者姓名:王玲
作者单位:杭州市红十字会医院急诊科,浙江杭州310003
摘    要:目的:观察益气复脉颗粒联合常规西药治疗慢性心力衰竭(CHF)的临床疗效.方法:将98例CHF患者随机分为观察组和对照组,各49例.对照组给予常规西药厄贝沙坦片、硝酸异山梨酯片、地高辛片等治疗,观察组在对照组治疗的基础上加服益气复脉颗粒治疗,2组连续治疗8周.评估2组临床疗效;比较2组治疗前后左心室舒张末径(LVEDD)...

关 键 词:慢性心力衰竭  益气复脉颗粒  心室重塑  炎症因子  B淋巴细胞-2

Clinical Study on Yiqi Fumai Prescription Combined with Routine Western Medicinefor Chronic Heart Failure
WANG Ling. Clinical Study on Yiqi Fumai Prescription Combined with Routine Western Medicinefor Chronic Heart Failure[J]. JOURNAL OF NEW CHINESE MEDICINE, 2021, 53(5): 55-58
Authors:WANG Ling
Abstract:Objective:To observe the clinical effect of Yiqi Fumai prescription combined with routine western medicine for chronic heart failure(CHF). Methods:A total of 98 cases of CHF patients were randomly divided into the observation group and the control group, 49 cases in each group. The control group was given routine western medicine including irbesartan tablets,isosorbide dinitrate tablets,and digoxin tablets;the observation group was additionally given the oral administration of Yiqi Fumai prescription based on the treatment of the control group. Both groups were continuously treated for 8 weeks.The clinical effect was evaluated in the two groups.Levels of left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD), and left ventricular ejection fraction(LVEF) before and after treatment were compared between the two groups. Levels of tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in serum before and after treatment were detected in the two groups.Gene expression levels of protein and mRNA of Bcl-2 before and after treatment were detected in the two groups. Results:The total effective rate was 91.84% in the observation group,and 77.55% in the control group, the difference being significant(P<0.05). After treatment, levels of LVESD and LVEDD as well as levels of TNF-α and IL-6 in serum in the two groups were decreased when compared with those before treatment(P<0.05);LVEF levels and expression levels of mRNA and protein of serum Bcl-2 in the two groups were increased when compared with those before treatment(P<0.05);the improvement of indexes above in the observation group was more significant than that in the control group(P<0.05). Conclusion: In the treatment of CHF, the combined therapy of Yiqi Fumai prescription and routine western medicine can effectively improve the heart function of patients with chronic heart failure, regulate inflammatory factors and gene expression level of mRNA of Bcl-2, whose curative effect is better than that of simple western medicine.
Keywords:Chronic heart failure  Yiqi Fumai prescription  Ventricular remodeling  Inflammatory factors  B lymphocyte-2
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《新中医》浏览原始摘要信息
点击此处可从《新中医》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号